Caris Life Sciences, Inc. is 1.1x more valuable than Celcuity Inc. by market capitalization ($4.85 B vs $4.30 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CELC | CAI |
|---|---|---|
| Market cap | $4.30 B | $4.85 B |
| US-listed rank | #1513 | #1404 |
| Revenue (latest FY) | - | $812.03M |
| Net income (latest FY) | -$177.04M | -$68.09M |
| Net margin | - | -8.4% |
| SEC filings | 506 | 102 |
Caris Life Sciences, Inc. is 1.1x more valuable than Celcuity Inc. by market capitalization ($4.85 B vs $4.30 B).
Full pages: Celcuity Inc. and Caris Life Sciences, Inc., or browse the full rankings.